Pay in 4 interest-free payments of $13.75 Learn more
Ships within 48 hours · Estimated delivery Aug 4 - Aug 9
resulting in constitutive activation
Specific inhibitors of the breast cancer resistance protein (BCRP)
The central Sirtuin 1/p53 pathway is essential for the orexigenic action of ghrelin
Smoothened Antagonists Reverse Taxane Resistance in Ovarian Cancer
Zhivkova Z
CIQ - CAS# 486427-17-2 size:2mg solid resulting in constitutive activationCIQ, CAS No. 486427 17 2, is a GluN2C GluN2D subunit selective NMDA receptor potentiator, which reverses MK 801 induced impairment in prepulse inhibition and working memory in Y maze test in mice. The facilitation of GluN2C GluN2D containing receptors may serve as an important therapeutic strategy for treating positive and cognitive symptoms in schizophrenia. Product information CAS Number: 486427 17 2 Molecular Weight: 467. 94 Formula: C26H26ClNO5
US$ 1127.51
US$ 1652.77
US$ 2703.01
US$ 1441.08
US$ 16100.00
US$ 2617.05
US$ 14150.00
US$ 2556.99
US$ 12950.00
US$ 52050.00
US$ 20300.00
US$ 9250.00